Home > Healthcare > Medical Devices > Therapeutic Devices > Cough Assist Devices Market
The rise in the prevalence of respiratory diseases testing has contributed considerably to the increased adoption of cough assist devices. Increasing patient pool of chronic obstructive pulmonary disease (COPD) and neuromuscular diseases is estimated to prove beneficial for industry growth. Neuromuscular disorders, such as muscular dystrophy, spinal muscular atrophy, and amyotrophic lateral sclerosis (ALS), can lead to weakened respiratory muscles and impaired cough function. Further, COPD is a progressive respiratory condition characterized by airflow limitation and breathing difficulties. For instance, as per the World Health Organization data, COPD caused around 3.23 million deaths and it was the third-leading cause of deaths globally. Thus, increasing patient population of COPD will surge the product adoption rate, thereby augmenting the market growth.